Inhibition of Nonfunctional Ras

Ruth Nussinov*, Hyunbum Jang, Attila Gursoy, Ozlem Keskin, Vadim Gaponenko*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations

Abstract

Nussinov et al. describe that the mechanism of mutational activation of kinases differs from Ras. Drug action should relate to the mechanism of activation, not to whether the protein is in active or inactive state. However, allosterically blocking the functional site will work for the inactive kinase and active Ras.

Original languageEnglish
Pages (from-to)121-133
Number of pages13
JournalCell Chemical Biology
Volume28
Issue number2
DOIs
StatePublished - 18 Feb 2021

Funding

FundersFunder number
National Institutes of HealthHHSN261200800001E
U.S. Department of Health and Human Services
National Cancer InstituteZIABC010441
NIH Clinical Center
Government of South Australia

    Keywords

    • K-Ras4B
    • KRAS
    • dimer
    • drug discovery
    • energy landscape
    • inhibitor
    • kinases

    Fingerprint

    Dive into the research topics of 'Inhibition of Nonfunctional Ras'. Together they form a unique fingerprint.

    Cite this